INNATE PHARMA SA (IDD.DE) Stock Analyst Ratings

FRA:IDD • FR0010331421

1.506 EUR
+0.02 (+1.21%)
Last: Jan 28, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to IDD.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 5.58. This target is 270.43% above the current price.
  • IDD.DE was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IDD.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • IDD.DE was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
IDD.DE Historical Analyst RatingsIDD.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.512.306.415.587.39 - 52.74% 325.41% 270.43% 390.66%

Related screens

Find peers 30% below price target
IDD.DE Current Analyst RatingIDD.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades

INNATE PHARMA SA / IDD.DE FAQ

Can you provide the average price target for INNATE PHARMA SA stock?

9 analysts have analysed IDD.DE and the average price target is 5.58 EUR. This implies a price increase of 270.43% is expected in the next year compared to the current price of 1.506.


How do analysts rate INNATE PHARMA SA (IDD.DE)?

The consensus rating for INNATE PHARMA SA (IDD.DE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.